Queen Elizabeth Hospital NHS Foundation Trust Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: King's Lynn United Kingdom (1980)

Organization Overview

First Clinical Trial
2000
NCT00150696
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Queen Elizabeth Hospital Birmingham | Queen Elizabeth Hospital, Birmingham, England | Queen Elizabeth Hospital, Birmingham UK | Queen Elizabeth Hospital NHS Foundation Trust | Queen Elizabeth II Health Sciences Centre, Victoria General Site | Queen Elizabeth Psychiatric Hospital, Birmingham | Queen Elizabeth Psychiatric Hospital, Birmingham, United Kingdom | Queen Elizabeth Psychiatric Hospital, United Kingdom | Queen Elizabeth University Hospital / Edgaston / Birmingham | The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust

Active Ingredients

Drugs in Phase 4 Trials (1)

donepezil (aricept) (1 trial)

Drugs in Phase 3 Trials (1)

risedronate (actonel) (1 trial)

Drugs in Phase 2 Trials (6)

apabetalone (1 trial)

apricoxib (1 trial)

azd9668 (1 trial)

cannabidiol (Epidiolex) (1 trial)

pbi-4050 (1 trial)

trx0014 (2 trials)

Drugs in Other Trials (1)

insulin human (humulin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alstrom Syndrome (Phase 2)

Alzheimer Disease (Phase 4)

Bronchiectasis (Phase 2)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Dementia (Phase 2)

Fabry Disease (Phase 2)

Fibrosis (Phase 2)

Inflammation (Phase 2)

Osteoporosis (Phase 3)

Pancreatic Neoplasms (Phase 2)

Spinal Cord Injuries (Phase 3)

Ulcer (Phase 2)

Wounds and Injuries (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 9